The account observed false elevated and imprecise architect calcium results when processing on multiple architect c16000 analyzers, serials (b)(4).Sid (b)(6).Calcium results ranged 3.62 to 3.07 mmol/l.A secondary tube generated calcium results ranged 5.22 to 3.25 mmol/l.Troubleshooting included replacing the sample probe, repeating on additional analyzers with continued imprecise results ranging 2.76 to 2.29 mmol/l.After transferring the specimen to a sample cup for processing results ranging 2.16 to 2.12 mmol/l.Sid (b)(6) generated results of 5.47, 3.22, 3.24, 2.87, 3.27, 1.85, 1.83 mmol/l on serial (b)(4).Sid (b)(6) generated results of 2.83 to 4.13 mmol/l.Sid (b)(6) generated results of 2.85 to 4.08 mmol/l.Sid (b)(6) generated results of 2.44 to 5.20 mmol/l.Sid (b)(6) generated results of 2.96 to 4.22 mmol/l.Sid (b)(6) generated results of 3.20 to 3.71 mmol/l on (b)(6) 2020 on serial (b)(4), but repeated on all 3 architect analyzers ranging from 1.98 to 2.63 mmol/l.No specific patient information was provided.
|
A review of tickets determined that there is normal complaint activity for complaint lot.Trending review of complaint product determined no adverse trend for erratic patient results due to the product.Return testing was not completed as returns were not available.Precision study when performed on the instrument using quality controls, was in specification.A review of the manufacturing documentation did not identify any issues associated with the customer observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the evaluation, no systemic issue or product deficiency of architect calcium reagent lot number 38264un20 was identified.
|